The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.4.2.2_13

 

contents  Detailed contents  << prev  next >>

  [Results]
1. PCBs and dioxins
1) Cohort studies
Weisglas-Kuperus et al. (2000) conducted a follow-up study on PCB and dioxin exposure in Holland involving 207 healthy Caucasian mother-infant pairs registered in Rotterdam in the period of June 1990-February 1992. PCB exposure was defined as the sum of PCB-118, 138, 153 and 180 in maternal blood, cord blood, breast milk and in the infant at 42 months of age. Also levels of 17 dioxins in breast milk were measured. Actual analysis covered 193 pairs. Prenatal PCB exposure was associated with less shortness of breath with wheeze (OR = 0.44, P = 0.05 for ΣPCB in maternal blood). Current PCB body burden was associated with a higher prevalence of recurrent middle-ear infections (OR = 3.06, P = 0.02 for ΣPCB in infant's blood) and of chicken pox (OR = 7.63, P = 0.03 for PCB in infant's blood), and a lower prevalence of asthma/bronchitis (OR = 0.01, P = 0.01 for ΣPCB in infant's blood). Breast milk TEQ of mono-ortho and planer PCBs was associated with a higher prevalence of recurrent middle-ear infections (OR = 1.17, P=0.01 for mono-ortho PCB TEQ; OR = 1.10, p=0.04 for planer PCB TEQ), and a higher dioxin TEQ with a higher prevalence of coughing, chest congestion, and phlegm (OR = 1.06, P = 0.04). Thus PCB exposure increases prevalence of infections, which may prevent development of allergy.
In the follow-up continued to schooling age (Weisglas-Kuperus et al., 2004) covering 167 pairs, perinatal PCB exposure was associated with lower prevalence of chicken pox between 3 and 7 years of age (OR = 0.53, P = 0.03 for breast milk ΣPCB; OR = 0.04, P = 0.02 for cord blood ΣPCB) and less shortness of breath with wheeze (OR = 0.59, P = 0.04 for maternal blood ΣPCB). Postnatal PCB exposure was related to recurrent middle-year infections (OR = 1.10, P = 0.04 for breast milk ΣPCB in lactating period). No consequent association with infections was recognized here (less chicken pox and more middle-year infections). It was now suggested that background PCB exposure affects the immune system.
Tusscher et al. (2003) evaluated effects on blood and immune system in a cohort consisting of 35 healthy Caucasian mother-infant pairs from Holland. Dioxin exposure was measured by the TEQ of dioxins except dioxin-like PCBs in breast milk, which was doubled to define the total dioxin TEQ. Perinatal exposure was defined as the initial dioxin TEQ in breast milk, and postnatal exposure was estimated by taking exposure during the lactating period into account.
Analysis of 27 pairs showed that perinatal dioxin exposure was related to lower incidence of allergic diseases (P = 0.023), as postnatal exposure was (P = 0.03).
 

contents  Detailed contents  << prev  next >>

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.